Exosens revenue and financials

EXENS · Euronext Paris · EUR

Compare Exosens
€50.00Change from previous close: −4.85%Absolute change: −€2.55

Close · November 20, 2026

In the fiscal year ended December 2025, Exosens reported revenue of €468.19M (+22.10% year over year). Net income was €42.72M, a net margin of 9.1%.

Annual revenue · 2025: €468.19M
  1. €149.86M2020
  2. €166.17M2021
  3. €200.75M2022
  4. €291.82M2023
  5. €383.44M2024
  6. €468.19M2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+22.10%
2025 vs 2024
Net income growth
+39.23%
2025 vs 2024
Net margin
9.1%
2024: 8.0%

How Exosens is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item202520242023202220212020
Total revenue468383292201166150
Cost of revenue18715812784.564.657.0
Gross profit28122616511610292.9
Selling, general and administrative13911184.564.657.753.2
Operating income10480.652.630.129.530.0
EBIT10480.652.630.129.530.0
EBITDA12996.471.943.635.034.9
Interest expense12.135.526.915.237.641.9
Pre-tax income88.245.720.217.1-150-13.2
Income tax18.011.61.85.9-1.32.6
Net income42.730.718.411.2-149-15.8
Net income to common shareholders70.228.97.40.8-149-15.8
Basic EPS1.380.690.240.01-1.96—
Diluted EPS1.380.690.240.01-1.96—
Average shares (basic)50.741.730.476.076.0—
Average shares (diluted)50.741.730.476.076.0—
Dividend per share0.300.10————

Companies in the group: same industry, similar size